Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Compound chlorzoxazone tablets

A technology of compound chlorzoxazone tablets and chlorzoxazone, which is applied in the fields of medical formula, organic active ingredients, muscular system diseases, etc., can solve the problem of one-sided treatment of soft tissue injuries, and achieve mild adverse reactions, enhanced effects, and good The effect of action

Inactive Publication Date: 2005-10-12
LUNAN PHARMA GROUP CORPORATION
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the therapeutic effects of both on soft tissue injuries are very one-sided. Therefore, it is necessary to consider combining the two to study a compound preparation that is more effective in treating soft tissue pain.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Chlorzoxazone 125g

[0015] Acetaminophen 125g

[0016] Starch 30g

[0017] Sodium carboxymethyl starch 8g

[0018] Magnesium stearate 3g

[0019] Preparation process: Pass acetaminophen and chlorzoxazone through a 80-mesh sieve, pass other excipients through a 100-mesh sieve, mix chlorzoxazone and acetaminophen according to the prescription ratio, add an appropriate amount of distilled water to granulate, add carboxylate after drying Sodium methyl starch and magnesium stearate are mixed and granulated, and pressed into 1000 tablets.

Embodiment 2

[0021] Chlorzoxazone 125g

[0022] Acetaminophen 150g

[0023] Starch 25g

[0024] Sodium carboxymethyl starch 12g

[0025] Magnesium stearate 3g

[0026] The preparation process is the same as in Example 1.

Embodiment 3

[0028] Chlorzoxazone 250g

[0029] Acetaminophen 375g

[0030] Starch 55g

[0031] Sodium carboxymethyl starch 20g

[0032] Magnesium Stearate 5g

[0033] The preparation process is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A compound Luzuoshazong tablet for treating myospasm and soft tissue pain is prepared from Luzuoshazong and paractamol in weight ratio of 1:1.2. Its advantage is high curative effect.

Description

technical field [0001] The invention relates to a compound preparation, in particular to a compound chlorzoxazone tablet for treating muscle spasm and relieving soft tissue pain, belonging to the field of medicine. Background technique [0002] Various soft tissue pains such as sprains, contusions, lumbar muscle strain, low back pain, and muscle spasms are common and frequently-occurring diseases in daily life, which have a serious impact on people's labor, work, study, and even daily life. [0003] Chlorzoxazone is suitable for sprains and contusions of various acute and chronic soft tissues (muscles, ligaments, fascia), muscle soreness after exercise and pain caused by muscle strain. It can also be used for the treatment of muscle spasms and chronic fasciitis caused by central nervous system diseases. It achieves the effect of eliminating pain and increasing the activity of diseased muscles by relieving muscle spasms. It is a good drug for relieving ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/423A61P21/02
Inventor 赵志全
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products